CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Conditions

• Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult Volunteers
• Breast Cancer

Interventions

• DRUG: Orialpha (BD-C)

Sponsor

Oriplantee Company Limited

Collaborators

• Vietstar Biomedical Research